191 related articles for article (PubMed ID: 28980424)
1. Development and validation of a nomogram predicting the overall survival of stage IV breast cancer patients.
Li S; Zhao J; Zhu L; Su F; Chen K
Cancer Med; 2017 Nov; 6(11):2586-2594. PubMed ID: 28980424
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Factors and Survival Outcomes among Patients with Breast Cancer and Brain Metastases at Diagnosis: A National Cancer Database Analysis.
Zimmerman BS; Seidman D; Cascetta KP; Ru M; Moshier E; Tiersten A
Oncology; 2021; 99(5):280-291. PubMed ID: 33652435
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic and extrinsic flaws of the nomogram predicting bone-only metastasis in women with early breast cancer: An external validation study.
Ouldamer L; Bendifallah S; Chas M; Boivin L; Bedouet L; Body G; Ballester M; Daraï E
Eur J Cancer; 2016 Dec; 69():102-109. PubMed ID: 27821312
[TBL] [Abstract][Full Text] [Related]
4. Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N3.
Wang J; Chen L; Nie Y; Wu W; Yao Y
Clin Breast Cancer; 2020 Dec; 20(6):e778-e785. PubMed ID: 32636150
[TBL] [Abstract][Full Text] [Related]
5. Racial disparity in estrogen receptor positive breast cancer patients receiving trimodality therapy.
Wright JL; Reis IM; Zhao W; Panoff JE; Takita C; Sujoy V; Gomez CR; Jorda M; Franceschi D; Hurley J
Breast; 2012 Jun; 21(3):276-83. PubMed ID: 22178596
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival.
Tarhan MO; Demir L; Somali I; Yigit S; Erten C; Alacacioglu A; Ellidokuz H; Seseogullari O; Kucukzeybek Y; Can A; Dirican A; Bayoglu V; Akyol M
Clin Exp Metastasis; 2013 Feb; 30(2):201-13. PubMed ID: 22915160
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a nomogram for predicting survival of advanced breast cancer patients in China.
Lin S; Mo H; Li Y; Guan X; Chen Y; Wang Z; Yuan P; Wang J; Luo Y; Fan Y; Cai R; Li Q; Chen S; Zhang P; Li Q; Ma F; Xu B
Breast; 2020 Oct; 53():172-180. PubMed ID: 32836201
[TBL] [Abstract][Full Text] [Related]
8. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
[TBL] [Abstract][Full Text] [Related]
9. Prognostic nomogram for patients with non-metastatic HER2 positive breast cancer in a prospective cohort.
Luo C; Zhong X; Wang Z; Wang Y; Wang Y; He P; Peng Q; Zheng H
Int J Biol Markers; 2019 Mar; 34(1):41-46. PubMed ID: 30852974
[TBL] [Abstract][Full Text] [Related]
10. Prognostic nomogram for female patients suffering from non-metastatic Her2 positive breast cancer: A SEER-based study.
Wu J; Xie Z; Xiao Y; Wang B; Zhang P
Medicine (Baltimore); 2022 Oct; 101(40):e30922. PubMed ID: 36221419
[TBL] [Abstract][Full Text] [Related]
11. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract][Full Text] [Related]
12. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
[TBL] [Abstract][Full Text] [Related]
13. Does race predict survival for women with invasive breast cancer?
Walsh SM; Zabor EC; Stempel M; Morrow M; Gemignani ML
Cancer; 2019 Sep; 125(18):3139-3146. PubMed ID: 31206623
[TBL] [Abstract][Full Text] [Related]
14. A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study.
Zhang H; Xie P; Li Z; Huang R; Feng W; Kong Y; Xu F; Zhao L; Song Q; Li J; Zhang B; Fan J; Qiao Y; Xie X; Zheng S; He J; Wang K
Diagn Pathol; 2019 May; 14(1):35. PubMed ID: 31054583
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a nomogram for predicting survival of breast cancer patients with ipsilateral supraclavicular lymph node metastasis.
Lyu MH; Ma YZ; Tian PQ; Guo HH; Wang C; Liu ZZ; Chen XC
Chin Med J (Engl); 2021 Nov; 134(22):2692-2699. PubMed ID: 34743149
[TBL] [Abstract][Full Text] [Related]
16. A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study.
Zhao W; Wu L; Zhao A; Zhang M; Tian Q; Shen Y; Wang F; Wang B; Wang L; Chen L; Zhao X; Dong D; Zhang L; Yang J
BMC Cancer; 2020 Oct; 20(1):982. PubMed ID: 33046035
[TBL] [Abstract][Full Text] [Related]
17. Nomogram for predicting preoperative regional lymph nodes metastasis in patients with metaplastic breast cancer: a SEER population-based study.
Zhang M; Wang B; Liu N; Wang H; Zhang J; Wu L; Zhao A; Wang L; Zhao X; Yang J
BMC Cancer; 2021 May; 21(1):565. PubMed ID: 34001061
[TBL] [Abstract][Full Text] [Related]
18. ER
Arciero CA; Guo Y; Jiang R; Behera M; O'Regan R; Peng L; Li X
Clin Breast Cancer; 2019 Aug; 19(4):236-245. PubMed ID: 30846407
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
Li H; Wang Z; Yang F; Wang J
J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
[TBL] [Abstract][Full Text] [Related]
20. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
